#hiv

All articles tagged with "hiv"

A Phase III HIV trial found once-weekly oral treatment was noninferior to daily therapy after 48 weeks.
More than 93% of participants in both groups maintained viral suppression.
The weekly regimen could reduce stigma, pill fatigue, and daily treatment burden for some patients.

DT Editorial Team·Jul 30, 2026·via medicalxpress.com

Two trial participants maintained undetectable HIV without ongoing medication after a single CAR-T infusion.
The study is early and small, focused on safety and feasibility rather than broad efficacy.
If replicated, the approach could push HIV treatment toward longer-lasting immune control.

DT Editorial Team·May 18, 2026·via wired.com

Researchers linked a blood-based aging signal to cognitive and mood-related depression symptoms.
The finding was highlighted in work involving women with HIV, who face elevated depression risk.
The result points toward more specific biomarkers rather than a single universal depression test.

DT Editorial Team·May 4, 2026·via medicalxpress.com

The FDA approved Idvynso for adults with HIV-1 who are already virologically suppressed.
The once-daily tablet combines doravirine and islatravir in a single pill.
Two randomized trials supported the approval by showing maintained viral suppression after switching.

DT Editorial Team·May 2, 2026·via medicalxpress.com

Researchers targeted the HIV apex, a conserved but sugar-shielded region of the virus.
The vaccine used HIV proteins attached to liposomes plus gradually altered boosters.
All vaccinated macaques developed antibodies that neutralized a broad range of HIV variants.

DT Editorial Team·Apr 29, 2026·via medicalxpress.com

A Manchester team says engineering biology can improve Lenacapavir production.
The reported advance combines cost reduction with sustainability goals.
Manufacturing innovation may become a major lever in access to advanced medicines.

DT Editorial Team·Apr 13, 2026·via phys.org

Karolinska Institutet researchers reported an association between gut bacteria composition and latent HIV levels
The finding concerns people receiving antiretroviral therapy
The study points to a potential new avenue for HIV persistence and cure research

DT Editorial Team·Apr 9, 2026·via medicalxpress.com

A study predicts HIV infections could rise 10% if CDC testing funds end.
Medical Xpress says timely diagnosis and treatment are critical to preventing transmission.
The report underscores the role of federally supported local testing programs in prevention.

DT Editorial Team·Apr 8, 2026·via medicalxpress.com